Find what you’re looking for
find what you’re looking for
Please note that Long-Term Illness (LTI) scheme approvals for mental illness under List P apply only to patients under 16 years of age. You are advised to regularly review patient eligibility to ensure that claims are not submitted after the patient turns 17 years of age, even if the LTI card does not show an […]
The HSE Living Well (Chronic Disease Self-Management) Programme is taking place at locations around the country over the coming months. This programme has been proven to increase self-efficacy and confidence, and improve health outcomes, in participants who live with long-term health conditions. Community Pharmacists can refer patients, and patients can also self-refer. Referrals can be […]
As you will be aware, the IPU has been engaging intensively with the Minister for Health, the Department of Health (DoH), and the HSE to develop a workable and sustainable approach to the HRT policy announced in Budget 2025. In recent months, we’ve submitted multiple proposals aimed at delivering a fair outcome, one that supports […]
COVID-19 Booster Vaccination Campaign Spring 2025 The COVID-19 Booster Vaccination Campaign Spring 2025 commenced on 3 April. The HSE is running a campaign on local and national radio, social media and Google search to coincide with the launch of the Spring Booster. The communications encourage people to contact their pharmacy, GP or HSELive to get […]
We are delighted to announce that the keynote speaker for the IPU National Pharmacy Conference 2025 is Dr Ronan Glynn, Health Sector Lead at EY and former Deputy Chief Medical Officer at the Department of Health (2018–2022). Dr Glynn played a key role in Ireland’s national response to COVID-19 and will discuss the shift from […]
You will be aware that the HSE has recently launched a tender for a national provider for NRT products as suggested by advisors under their stop smoking service. The provision of NRT products for this service has been considered by IPU committees and several discussions have taken place with the IPU and the HSE as […]
The November edition of the HPRA Drug Safety Newsletter includes a recent update regarding Fluconazole. The key messages of the update are: Before initiating treatment in women of childbearing potential, it is advised to inform the patient of the potential risks to the foetus – risk of spontaneous abortion, risk of cardiac malformations and other […]
LAIV Supply The NIO has advised that orders for LAIV stock remain open, and it is anticipated that sites will be able to order the remainder of their allocations for delivery from 21 October onwards, as per their NCCS delivery schedules. Orders will continue in two weekly cycles. HSE PharmaVax Off-site Vaccination Functionality New […]
IPU NIO Autumn Winter Vaccination Programme 2024/2025 Webinar The IPU in collaboration with the National Immunisation Office (NIO) hosted a webinar on the Autumn Winter Vaccination Programme 2024/2025. A recording of the webinar can be viewed on the IPU Vaccination Hubs. HSE Combined COVID-19 and Flu Consent Form The HSE has made available an […]
On August 14 HIQA published their rapid assessment of immunisation against respiratory syncytial virus (RSV) in Ireland. The assessment noted the following: The estimated one-year cost of immunising infants for their first RSV season ranged from €3.9 to €19 million depending on the strategy used, and would be partially offset by fewer hospitalisations. The estimated […]
